Calamos Advisors’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-78,280
Closed -$7.44M 734
2018
Q3
$7.44M Sell
78,280
-16,760
-18% -$1.43M 0.04% 368
2018
Q2
$7.34M Sell
95,040
-14,591
-13% -$1.09M 0.04% 365
2018
Q1
$7.57M Buy
109,631
+5,180
+5% +$395K 0.05% 358
2017
Q4
$7.8M Sell
104,451
-2,215
-2% -$142K 0.04% 334
2017
Q3
$6.75M Buy
106,666
+3,909
+4% +$243K 0.05% 331
2017
Q2
$6.56M Sell
102,757
-2,292
-2% -$144K 0.05% 339
2017
Q1
$6.92M Sell
105,049
-353
-0.3% -$24.3K 0.05% 325
2016
Q4
$7.25M Sell
105,402
-1,303
-1% -$93.4K 0.06% 306
2016
Q3
$7.53M Sell
106,705
-1,633
-2% -$122K 0.05% 301
2016
Q2
$8.21M Sell
108,338
-823,459
-88% -$60.5M 0.06% 289
2016
Q1
$64M Buy
931,797
+830,237
+817% +$59.7M 0.42% 64
2015
Q4
$8.88M Buy
101,560
+1,650
+2% +$141K 0.06% 277
2015
Q3
$8.09M Sell
99,910
-2,815
-3% -$245K 0.06% 285
2015
Q2
$9.14M Sell
102,725
-5,634
-5% -$492K 0.06% 280
2015
Q1
$9.4M Buy
108,359
+2,912
+3% +$244K 0.06% 275
2014
Q4
$8.93M Sell
105,447
-24,453
-19% -$1.91M 0.06% 279
2014
Q3
$9.18M Sell
129,900
-940
-0.7% -$67K 0.06% 266
2014
Q2
$9.07M Buy
130,840
+30,840
+31% +$2.17M 0.06% 264
2014
Q1
$7.51M Buy
100,000
+30,000
+43% +$2.25M 0.05% 272
2013
Q4
$4.92M Hold
70,000
0.03% 317
2013
Q3
$4.33M Hold
70,000
0.03% 314
2013
Q2
$4.32M Buy
+70,000
New +$4.22M 0.03% 304

Other funds holding ESRX

Calamos Advisors's ESRX Position: Q4 2018 in Review

Calamos Advisors sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 78,280 shares — an estimated $7.44M sold.

Calamos Advisors first reported a position in ESRX in Q2 2013 and held it in 22 quarters. The position peaked at $64M in Q1 2016. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Calamos Advisors reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Calamos Advisors sold 78,280 Express Scripts Holding Company shares in Q4 2018, an estimated $7.44M.
  • Calamos Advisors first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 22 quarters.
  • Calamos Advisors's Express Scripts Holding Company position peaked at $64M in Q1 2016.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Calamos Advisors's 13F filing for Q4 2018, filed 24 Jan 2019.